Status:
RECRUITING
A DirEct to PatieNt Study in Chronic Pain
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Chronic Pain
Eligibility:
All Genders
22+ years
Brief Summary
To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/proced...
Eligibility Criteria
Key Inclusion Criteria:
- Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting
- Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening
- Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English
Key Exclusion Criteria:
- Requires a legal representative to sign the ICF ascertained from self-reporting
Key Trial Info
Start Date :
January 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT05515341
Start Date
January 10 2023
End Date
December 1 2029
Last Update
April 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Scientific Neuromodulation
Valencia, California, United States, 91355